Brief: Bellevue Life Sciences Acquisition Corp. And Osr Holdings Sign An Exclusive Letter Of Intent For A Business Combination
11/07/2023 21:56
July 11 (Reuters) - Bellevue Life Sciences Acquisition
Corp BLAC.O :
* BELLEVUE LIFE SCIENCES ACQUISITION CORP. AND OSR HOLDINGS
SIGN
AN EXCLUSIVE LETTER OF INTENT FOR A BUSINESS COMBINATION
* BELLEVUE LIFE SCIENCES ACQUISITION CORP: OSR HOLDINGS
EXPECTED
TO BE PUBLIC IN Q4 OF 2023
* BELLEVUE LIFE SCIENCES ACQUISITION CORP - UPON COMPLETION
OF
BUSINESS COMBINATION, SURVIVING COMPANY WILL BE RENAMED AS OSR
BIOSCIENCES, INC
* BELLEVUE LIFE SCIENCES ACQUISITION CORP: CO, OSR EXPECT TO
FINALIZE DEFINITIVE AGREEMENT WITH RESPECT TO PROPOSED BUSINESS
COMBINATION IN COMING WEEKS
Source text for Eikon: ID:nPn2sZwha
Further company coverage: BLAC.O
Recent news on OSR Health
See all newsBrief: OSR Holdings Changes Corporate Name To OSR Health, Effective June 11, 2026
Brief: Osr Holdings Inc - In Preliminary Discussions For Acquisition Of 16% Controlling Stake In Sillajen - SEC Filing
Brief: Osr Holdings Inc - Vaximm AG Enters Binding Term Sheet With Bcm Europe AG - SEC Filing
Brief: Vaximm, An Osr Company, Receives Binding Term Sheet From Bcm Europe For Global Exclusive License Of Vxm01 With $30M Upfront And Up To $815M In Milestones
Brief: OSR Holdings Says Woori IO Shareholders Approve Share Exchange To Become Unit Of Co